Urges Hawaii State Director of Health to allow sale of nebulized budesonide without prescription for COVID-19 treatment.

This bill urges the Hawaii State Director of Health to issue a statewide order permitting the sale and purchase of nebulized budesonide without a prescription or consultation with a healthcare provider. The bill cites studies showing that inhaled budesonide reduces the need for urgent medical care, shortens recovery time, and lowers the risk of hospitalization for COVID-19 patients. It also references global acceptance and recommendations from health authorities in the U.K., Australia, and India for using budesonide in treating COVID-19.

Urges Hawaii State Director of Health to allow sale of nebulized budesonide without prescription for COVID-19 treatment.

This bill urges the Hawaii State Director of Health to issue a statewide order permitting the sale and purchase of nebulized budesonide without a prescription or consultation with a healthcare provider. The bill cites studies showing that inhaled budesonide reduces the need for urgent medical care, shortens recovery time, and lowers the risk of hospitalization for COVID-19 patients. It also references global acceptance and recommendations from health authorities in the U.K., Australia, and India for using budesonide in treating COVID-19.